Wellinks has raised $10.0M in a Series B round, with University of Massachusetts Memorial Health (UMMH) and internal investors providing the capital.
The company builds COPD disease management programs that pair respiratory specialists and health coaches with a connected-device kit and an app, aiming to extend care beyond the doctor’s office. The fresh funding arrives as UMMH deepens its involvement, though Wellinks hasn’t detailed how the money will be deployed.

















